Esperion Therapeutics | Pre Utilidad Fiscal





Pre Utilidad Fiscal Cambio Fecha
AbbVie USD 4.38B 1.92B 2025-09
Alnylam Pharmaceuticals USD 238.97M 274.33M 2025-09
Alterity Therapeutics Limited AUD -4.74M 3.53M 2024-12
Amarin USD -8.12M 5.34M 2025-09
Amgen USD 3.92B 2.35B 2025-09
Biogen USD 557.3M 186.7M 2025-09
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
Cipla INR 11.69B 6.85B 2025-12
CSL USD 1.4B 1.14B 2025-06
Cytokinetics USD -306.18M 171.81M 2025-09
Daiichi Sankyo JPY 106.73B 48.96B 2025-12
Eli Lilly USD 7.23B 456M 2025-09
Esperion Therapeutics USD 67.66M 3.6M 2024-09
Geron USD -18.43M 2.05M 2025-09
Grifols EUR 66.98M 19.92M 2024-06
Halozyme Therapeutics USD 218.96M 14.02M 2025-09
Heron Therapeutics USD -4.85M 4.39M 2024-09
Ionis Pharmaceuticals USD -129M 253M 2025-09
Merck USD 6.74B 22M 2025-09
Minerva Neurosciences USD 22.51M 30.74M 2024-09
Moderna USD -187M 631M 2025-09
Nektar Therapeutics USD -37.05M 15.27M 2024-09
Pfizer USD 3.33B 290M 2025-09
PTC Therapeutics USD -23.07M 47.98M 2025-09
Puma Biotechnology USD 20.61M 24.76M 2024-09
Regeneron Pharmaceuticals USD 1.76B 244.6M 2025-09
Sanofi EUR -1.16B 5.5B 2025-12
Sarepta Therapeutics USD -194.05M 347.69M 2025-09
United Therapeutics USD 438M 29.6M 2025-09
Vanda Pharmaceuticals USD -22.92M 16.68M 2024-12


Esperion Therapeutics Pre Utilidad Fiscal - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Feb 2026.